BMY

Bristol-Myers Squibb Company · NYSE · Healthcare · USD · 10-K for 2025, filed 2026-02-11

Figures on this page computed 2026-11-08 12:01 UTC

Last close

62.14USD

Market data, 2026-11-06

Except where said otherwise: 10-K for 2025, filed 2026-02-11

  • 17.9xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Fiscal year
    2025
    Accession
    0000014272-26-000004
    Reported in
    USD
    • computed
    • 10-K for 2025, filed 2026-02-11

    The filing itself

  • 15.3%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Fiscal year
    2025
    Accession
    0000014272-26-000004
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-11
    • 10-K for 2025, filed 2026-02-11
    • 10-K for 2025, filed 2026-02-11
    • 10-Q for 2025, filed 2026-10-29
    • 10-K for 2025, filed 2026-02-11
    • 10-Q for 2025, filed 2026-10-29

    The filing itself

  • 14.6%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0000014272-26-000004
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-11
    • 10-K for 2025, filed 2026-02-11

    The filing itself

  • 26.6%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0000014272-26-000004
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-11
    • 10-K for 2025, filed 2026-02-11

    The filing itself

  • 2.55Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Fiscal year
    2025
    Accession
    0000014272-26-000004
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-11
    • 10-Q for 2025, filed 2026-10-29

    The filing itself

  • 4.1%Dividend yield
    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • computed
    • computed
    • computed
    • computed
    • computed
    • Computed from the filing for 2025, filed 2026-02-11

What it sells, to whom

lens 8 of 9

Where it sells it

2
UNITED STATES33,279,000,000 USD96.8%
Other Region1,087,000,000 USD3.2%

Who it sells it to

1
McKesson Corporation36%

Each band is a share of itself. A segment and a place are two cuts of the same revenue, so they are never added together.

0 segments, 2 places and 1 named customers, each as the filer published it.

0 segments, 2 places and 1 named customers, each as the filer published it.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-02-11

  • UNITED STATES33,279,000,000
    Source
    filed
    Statement
    revenue_mix
    Fiscal year
    2025
    Accession
    0000014272-26-000004
    Reported in
    USD

    The filing itself

  • Other Region1,087,000,000
    Source
    filed
    Statement
    revenue_mix
    Fiscal year
    2025
    Accession
    0000014272-26-000004
    Reported in
    USD

    The filing itself

  • McKesson Corporation36.0%
    Source
    filed
    Statement
    concentration
    Fiscal year
    2025
    Accession
    0000014272-26-000004

    The filing itself

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.